<![CDATA[26 A Nomogram for Predicting High Axillary Disease Burden in Patients With Localized HR+, HER2-Negative Breast Cancer Following Neoadjuvant Chemotherapy]]>

Summary

A nomogram was developed to predict high axillary disease burden in 167 HR+/HER2- breast cancer patients following neoadjuvant chemotherapy, identifying lymphovascular invasion and sentinel node positivity as key predictive factors for guiding axillary management.